Indoles and their therapeutic use

Compound of formula (I) are ligands of the CRTH2 receptor, useful inter alia for treatment of inflammatory conditions. Wherein X is -SO2- or *-SO2NR3- wherein the bond marked with an asterisk is attached to Ar1; R1 is hydrogen, fluoro, chloro, CN or CF3; R2 is hydrogen, fluoro or chloro; R3 is hydro...

Full description

Saved in:
Bibliographic Details
Main Authors ARIENZO ROSA, FINCH HARRY, MONTANA JOHN GARY, DOMOSTOJ MATHIAS, AVITABILE-WOO BARBARA, HYND GEORGE
Format Patent
LanguageEnglish
Published 12.03.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Compound of formula (I) are ligands of the CRTH2 receptor, useful inter alia for treatment of inflammatory conditions. Wherein X is -SO2- or *-SO2NR3- wherein the bond marked with an asterisk is attached to Ar1; R1 is hydrogen, fluoro, chloro, CN or CF3; R2 is hydrogen, fluoro or chloro; R3 is hydrogen, C1C8alkyl or C3-C7cycloalkyl; Ar1 is phenyl or a 5- or 6-membered heteroaryl group selected from furanyl, thienyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, pyridinyl, pyridazinyl, pyrimidinyl and pyrazinyl, wherein the phenyl or heteroaryl groups are optionally substituted by one or more substituents independently selected from fluoro, chloro, CN, C3-C7cycloalkyl, -O(C1-C4alkyl) or C1C6alkyl, the latter two groups being optionally substituted by one or more fluoro atoms; and Ar2 is phenyl or 5- or 6-membered heteroaryl group selected from pyrrolyl, furanyl, thienyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, pyridinyl, pyridazinyl, pyrimidinyl and pyrazinyl, wherein the phenyl or heteroaryl groups are optionally substituted by one or more substituents independently selected from fluoro, chloro, CN, C3-C3-C7cycloalkyl, -O(C1-C4alkyl) or C1C6alkyl, the latter two groups being optionally substituted by one or more fluoro atoms.
AbstractList Compound of formula (I) are ligands of the CRTH2 receptor, useful inter alia for treatment of inflammatory conditions. Wherein X is -SO2- or *-SO2NR3- wherein the bond marked with an asterisk is attached to Ar1; R1 is hydrogen, fluoro, chloro, CN or CF3; R2 is hydrogen, fluoro or chloro; R3 is hydrogen, C1C8alkyl or C3-C7cycloalkyl; Ar1 is phenyl or a 5- or 6-membered heteroaryl group selected from furanyl, thienyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, pyridinyl, pyridazinyl, pyrimidinyl and pyrazinyl, wherein the phenyl or heteroaryl groups are optionally substituted by one or more substituents independently selected from fluoro, chloro, CN, C3-C7cycloalkyl, -O(C1-C4alkyl) or C1C6alkyl, the latter two groups being optionally substituted by one or more fluoro atoms; and Ar2 is phenyl or 5- or 6-membered heteroaryl group selected from pyrrolyl, furanyl, thienyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, pyridinyl, pyridazinyl, pyrimidinyl and pyrazinyl, wherein the phenyl or heteroaryl groups are optionally substituted by one or more substituents independently selected from fluoro, chloro, CN, C3-C3-C7cycloalkyl, -O(C1-C4alkyl) or C1C6alkyl, the latter two groups being optionally substituted by one or more fluoro atoms.
Author ARIENZO ROSA
FINCH HARRY
AVITABILE-WOO BARBARA
MONTANA JOHN GARY
DOMOSTOJ MATHIAS
HYND GEORGE
Author_xml – fullname: ARIENZO ROSA
– fullname: FINCH HARRY
– fullname: MONTANA JOHN GARY
– fullname: DOMOSTOJ MATHIAS
– fullname: AVITABILE-WOO BARBARA
– fullname: HYND GEORGE
BookMark eNrjYmDJy89L5WRQ9MxLyc9JLVZIzEtRKMlIzSwCkUWJBamlJZnJCqXFqTwMrGmJOcWpvFCam0HBzTXE2UM3tSA_PrW4IDE5NS-1JD402MLY0sTC2MzJyJgIJQASVScy
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US8394836B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US8394836B23
IEDL.DBID EVB
IngestDate Fri Jul 19 13:58:22 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US8394836B23
Notes Application Number: US20080746104
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130312&DB=EPODOC&CC=US&NR=8394836B2
ParticipantIDs epo_espacenet_US8394836B2
PublicationCentury 2000
PublicationDate 20130312
PublicationDateYYYYMMDD 2013-03-12
PublicationDate_xml – month: 03
  year: 2013
  text: 20130312
  day: 12
PublicationDecade 2010
PublicationYear 2013
RelatedCompanies ARIENZO ROSA
PULMAGEN THERAPEUTICS (ASTHMA) LIMITED
FINCH HARRY
AVITABILE-WOO BARBARA
MONTANA JOHN GARY
DOMOSTOJ MATHIAS
HYND GEORGE
RelatedCompanies_xml – name: ARIENZO ROSA
– name: PULMAGEN THERAPEUTICS (ASTHMA) LIMITED
– name: AVITABILE-WOO BARBARA
– name: DOMOSTOJ MATHIAS
– name: HYND GEORGE
– name: MONTANA JOHN GARY
– name: FINCH HARRY
Score 2.8822012
Snippet Compound of formula (I) are ligands of the CRTH2 receptor, useful inter alia for treatment of inflammatory conditions. Wherein X is -SO2- or *-SO2NR3- wherein...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Indoles and their therapeutic use
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130312&DB=EPODOC&locale=&CC=US&NR=8394836B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVbG-WEFyW8xj07SHIORFFWyLbaS3kn0EeonFpPTvd7KktRe9LbuwL_hm5pudmQV4NnNksqiIaM6UokwISblrZQg8yS3Pyk0hdbTFqDdM2fvcnbdgucuF0XVCN7o4IiJKIN4rLa9Xv06sSMdWli98iV3fr8nMj4yGHdcC2bKNKPDjyTgah0YY-unUGH36aAewvtMLUFofoRXt1WCIv4I6KWV1qFGSczie4GRFdQEtVXTgNNx9vNaBk4_mvRubDfTKS3h6K3TxJYLUn2j3PjnInSLrUl0BSeJZOKS41mJ_rkU63e_KuYY20n11A0QNsppFSMYGgnHPzVxH9F2upDTRWLBlF7p_TnP7z9gdnNn6KweHWvY9tKuftXpAhVrxR30VWwB_enI
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq2J9RpDcgnlsmvYQhLxItU2LTaS30M1uoJe0mBT_vpMlrb3obdmFfcE3M9_szCzAs5ojk0VFpOSEc4VkGVOoqS0ReIxqlparGRPRFlE_TMjbwly0YLXLhRF1Qr9FcUREVIZ4r4S83vw6sTwRW1m-0BV2rV-D2Pbkhh3XAlnTZc-x_dnUm7qy69rJXI4-bLQDyMDoOyitj9DCtmow-J9OnZSyOdQowRkcz3CyojqHFi-60HF3H6914WTSvHdjs4FeeQFPo0IUX5KQ-kvCvS8d5E5J25JfghT4sRsquFa6P1eazPe7Mq6gjXSfX4PEh8uaRTBChhmhlrk0jWxgUs6YisaCznrQ-3Oam3_GHqETxpNxOh5F77dwqotvHQxF0--gXX1t-T0q14o-iGv5AelDfWU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Indoles+and+their+therapeutic+use&rft.inventor=ARIENZO+ROSA&rft.inventor=FINCH+HARRY&rft.inventor=MONTANA+JOHN+GARY&rft.inventor=DOMOSTOJ+MATHIAS&rft.inventor=AVITABILE-WOO+BARBARA&rft.inventor=HYND+GEORGE&rft.date=2013-03-12&rft.externalDBID=B2&rft.externalDocID=US8394836B2